News
The “Top 10” list of best-selling gene therapies published by Genetic Engineering & Biotechnology News (GEN) in their May 2025 issue features three products based upon license agreements for technologies originating from the NIH Intramural Research Program. Featured and ranked on the GEN list are
Primary mediastinal B-cell lymphoma (PMBCL) is a non-Hodgkin lymphoma that accounts for 5-7% of all aggressive lymphomas. Diagnosing PMBCL can be challenging as the features overlap with diffuse large B-cell lymphoma (DLBCL), another type of non-Hodgkin lymphoma. These two lymphomas respond
Researchers at the National Cancer Institute (NCI) have developed a diagnostic assay that detects sequence-specific (viral) RNA. This technology describes an RNase-H-assisted detection assay for RNA (RADAR) that is rapid, inexpensive, and highly sequence-specific. There is a great need for this
The Maryland Department of Economic Development just released a great new guide to technology transfer in Maryland. Maryland is home to 78 federal laboratories, including 27 Institutes/Centers from the National Institutes of Health (NIH) and is filled with excellent partnering opportunities. This